Disclosures for "Study Design of TAK-341-2001: A Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-341 in Subjects With Multiple System Atrophy")
-
Jaya Padmanabhan has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Jaya Padmanabhan has stock in Takeda Pharmaceuticals.
-
Dr. Ratti has received personal compensation for serving as an employee of Takeda. Dr. Ratti has received personal compensation for serving as an employee of Biogen. Dr. Ratti has stock in Takeda. Dr. Ratti has stock in Biogen.
-
Dr. Khudyakov has nothing to disclose.
-
Wei Yin has nothing to disclose.
-
Mr. Zicha has stock in Takeda Pharmaceutical Company Ltd.
-
Dr. Golonzhka has nothing to disclose.
-
Tairmae Kangarloo has nothing to disclose.
-
Brian Harel has received personal compensation for serving as an employee of Takeda. An immediate family member of Brian Harel has received personal compensation for serving as an employee of Astra Zeneca. Brian Harel has stock in Takeda, Merck, Day One Biopharmaceuticals. An immediate family member of Brian Harel has stock in Eli Lilly, Pfizer, Astra Zeneca.
-
Mrs. Goodman has nothing to disclose.
-
Mrs. Magueur has received personal compensation for serving as an employee of Takeda . Mrs. Magueur has stock in Takeda Pharmaceuticals.
-
Dr. Shering has received personal compensation for serving as an employee of AstraZeneca. Dr. Shering has stock in AstraZeneca. Dr. Shering has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Ostenfeld has received personal compensation for serving as an employee of AstraZeneca. Dr. Ostenfeld has stock in AstraZeneca. Dr. Ostenfeld has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Laurenza has received personal compensation for serving as an employee of Takeda. Dr. Laurenza has stock in Takeda.
-
Arthur Simen has received personal compensation for serving as an employee of Takeda.